Page last updated: 2024-10-29

iohexol and Hyperparathyroidism, Primary

iohexol has been researched along with Hyperparathyroidism, Primary in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Hyperparathyroidism, Primary: A condition of abnormally elevated output of PARATHYROID HORMONE due to parathyroid HYPERPLASIA or PARATHYROID NEOPLASMS. It is characterized by the combination of HYPERCALCEMIA, phosphaturia, elevated renal 1,25-DIHYDROXYVITAMIN D3 synthesis, and increased BONE RESORPTION.

Research Excerpts

ExcerptRelevanceReference
"Twenty patients had solitary parathyroid adenomas, two patients had two adenomas resected, two patients did not have an adenoma, and one patient had mild four-gland hyperplasia."1.37Dynamic MDCT for localization of occult parathyroid adenomas in 26 patients with primary hyperparathyroidism. ( Beland, MD; Grand, DJ; Machan, JT; Mayo-Smith, WW; Monchik, JM, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beland, MD1
Mayo-Smith, WW1
Grand, DJ1
Machan, JT1
Monchik, JM1

Other Studies

1 other study available for iohexol and Hyperparathyroidism, Primary

ArticleYear
Dynamic MDCT for localization of occult parathyroid adenomas in 26 patients with primary hyperparathyroidism.
    AJR. American journal of roentgenology, 2011, Volume: 196, Issue:1

    Topics: Adenoma; Adult; Aged; Aged, 80 and over; Contrast Media; Female; Four-Dimensional Computed Tomograph

2011